Neurodevelopment and Metabolism in the Maternal-Placental-Fetal Unit

Mariana Parenti1,2, Rebecca J Schmidt3,4, Daniel J Tancredi5

  • 1Department of Nutrition, University of California, Davis.

JAMA Network Open
|May 28, 2024
PubMed

Insights

Placental and umbilical cord serum metabolism in mothers of children with autism spectrum disorder (ASD) are linked to non-typical development risk. These metabolic profiles in siblings at high familial risk for ASD show significant correlations.

Area of Science:

  • Perinatal and developmental biology
  • Metabolomics
  • Neurodevelopmental disorders

Background:

  • Maternal, placental, and fetal metabolism influence developmental outcomes.
  • The interplay between the maternal-placental-fetal metabolic unit and child neurodevelopment, particularly in autism spectrum disorder (ASD) risk, remains understudied.

Purpose of the Study:

  • To investigate metabolic associations within the maternal-placental-fetal unit.
  • To examine the relationship between these metabolic profiles and neurodevelopmental outcomes in younger siblings of children with ASD.

Main Methods:

  • A prospective cohort study of younger siblings of children with ASD within the Markers of Autism Risk in Babies, Learning Early Signs (MARBLES) cohort.
  • Quantitative metabolomics analysis of maternal third-trimester serum, placental tissue, and umbilical cord serum.
  • Neurodevelopmental outcomes assessed using standardized measures and classified as ASD, other non-typical development (non-TD), or typical development (TD).

Main Results:

  • Placental and umbilical cord serum metabolomes were highly correlated (R² = 0.75, P < .001).
  • Placental and cord serum metabolic profiles were significantly associated with a reduced risk of non-TD (Relative Risk [RR] ≈ 0.13, P < .05) but not ASD.
  • No significant association was found between maternal third-trimester serum metabolome and other metabolomes or neurodevelopmental outcomes.

Conclusions:

  • Placental and cord serum metabolism are highly correlated in pregnancies with high familial risk for ASD.
  • These metabolic profiles are associated with the risk of non-typical development in offspring.
  • Further research into the maternal-placental-fetal metabolic unit may offer insights into neurodevelopmental trajectories.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
939
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
1.4K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
921
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
196